- Business Wire•2 days ago
GTx, Inc. announced today positive initial data from its ongoing open-label enobosarm Phase 2 clinical trial in women with advanced, estrogen receptor positive , androgen receptor positive breast cancer.
- Investopedia•3 days ago
Nasdaq’s minimum $1-per-share bid requirements for continued listing has forced GTx to declare a reverse stock split.
- Business Wire•5 days ago
GTx, Inc. today announced a reverse stock split of its shares of common stock at a ratio of one-for-ten. The reverse stock split will be effective at 5:00 p.m. Eastern Time on December 5, 2016.
GTXI : Summary for GTx, Inc. - Yahoo Finance
GTx, Inc. (GTXI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.39 x 2500|
|Ask||6.80 x 900|
|Day's Range||6.41 - 6.89|
|52 Week Range||0.29 - 7.33|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-52.08|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|